The FDA has cleared Tandem’s Control-IQ technology as the first ever AID specifically for use in pregnancies complicated by ...
MiniMed Group, Inc. (MiniMed; Nasdaq: MMED), a global leader in insulin delivery, announced Health Canada has licensed new ...
As technology becomes more integrated and personalized, experts say the biggest opportunity in diabetes management is ...
Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global ...
Report OverviewThe global insulin pumps market is projected to grow at a rate of 12% by 2028, fueled by rising diabetes ...
LAKEWOOD, CO, UNITED STATES, April 27, 2026 /EINPresswire.com/ -- The American Animal Hospital Association (AAHA) today ...
Glooko, Inc., a globally integrated digital healthcare company focused on helping healthcare systems solve the growing ...
As quantum computers advance, they are expected to be able to break tried-and-true security schemes that currently keep most ...
Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at the Bank of America Securities ...
Recent research and clinical updates highlight how GLP-1 receptor agonists are transforming diabetes and obesity care, with expanding uses from adolescents with type 2 diabetes to off-label ...
Research suggests umbilical cord blood may indicate early risk factors for Type 1 diabetes, offering potential for proactive ...
The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts. By Angelica P ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results